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Abstract 
 
Amodiaquine is an antimalarial drug used in the prophylaxis and treatment of this disease. However, 
hepatotoxicity as a life-threatening adverse effect is associated with its clinical use. We evaluated 
amodiaquine-induced toxicity in isolated rat hepatocytes as an in vitro model for studying drug-induced 
hepatotoxicity. This study attempts to investigate the protective effects of taurine and N-acetyl cysteine 
against the cytotoxicity induced by amodiaquine. Hepatocytes were prepared by the method of collagenase 
enzyme perfusion via portal vein. This technique is based on liver perfusion with collagenase after removal 
of calcium ion (Ca2+) with a chelator (ethylene glycol tetraacetic acid (EGTA) 0.5 mM). Cells were treated 
with different concentrations of amodiaquine, taurine and N-acetyl cysteine. Cell death, protein 
carbonylation, reactive oxygen species formation, lipid peroxidation, and mitochondrial depolarization were 
assessed as toxicity markers. Amodiaquine cytotoxic mechanism involved protein carbonylation as well as 
reactive oxygen species formation and lipid peroxidation. In addition, mitochondria seem to be a target for 
amodiaquine to induce cellular damage. Administration of taurine (200 µM) and/or N-acetyl cysteine (200 
µM) reduced oxidative stress, lipid peroxidation and protein carbonylation caused by amodiaquine. 
Furthermore, amodiaquine-induced mitochondrial injury was significantly mitigated by taurine and/or N-
acetyl cysteine. In glutathione-depleted cells, only N-acetyl cysteine protected hepatocytes against 
amodiaquine, and taurine showed no protective properties in this situation. Taurine and N-acetyl cysteine 
protect hepatocytes against amodiaquine probably via their antioxidant properties and counteracting 
oxidative stress. 
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INTRODUCTION 
 
Amodiaquine is used in the prophylaxis and 
treatment of malaria especially against 
chloroquine-resistant isolates of Plasmodium 
falciparum (1). However, the clinical use of this 
drug is associated with hepatotoxicity (2,3). The 
exact mechanism of amodiaquine-induced 
hepatotoxicity is not clear yet, but this adverse 
effect has been attributed to the bioactivation 
of the drug to a quinoneimine metabolite (4). 
Oxidative stress has been suggested                
to be involved in the development of 
amodiaquine-induced hepatotoxicity due to the 
ability of redox cycling induction by the 
quinoneimine metabolite of amodiaquine (5,6). 
Such reactive metabolites can irreversibly bind 
to proteins, which might lead to toxicity by 
disrupting the cell functions. Since reactive 
intermediates are formed during amodiaquine 
metabolism, amodiaquine toxicity mechanism 
could involve protein carbonylation. Lipid 
peroxidation is a consequence of oxidative 
stress (7). It has been shown that lipid 
peroxidation occurred after amodiaquine 
treatment (8,9). Glutathione reservoirs seems to 
have critical role in preventing amodiaquine 
hepatotoxicity (10). Hence, in present study, 
amodiaquine-induced cytotoxicity was 
evaluated in intact and glutathione-depleted 
hepatocytes to elucidate the role of glutathione 
reservoirs in the toxicity induced by this drug. 
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Taurine , a conditionally essential amino 
acid, has several physiological roles (11). 
There are many reports on taurine protective 
effects against different chemicals-induced 
hepatotoxicity (12-14). It has been reported 
that this amino acid could act as an antioxidant 
in biological systems (15). Hence, the protective 
effects of taurine could be due to the antioxidant 
capability of this amino acid. Being an 
antioxidant, it has also the ability to scavenge 
the reactive oxygen species; attenuate lipid 
peroxidation, and consequently stabilize the 
biological membranes (16,17). 
Considering the previously reported hepato-
toxicity associated with amodiaquine, it becomes 
imperative to study on effective protective 
agents, which could reduce liver injury caused 
by this drug. Since taurine has shown protective 
properties such as antioxidative (18), lipid 
peroxidation attenuating (19), and/or cellular 
membrane stabilizing (20) , this study 
attempted to evaluate the potential protective 
effects of this amino acid against 
amodiaquine-induced cellular injury. N-acetyl 
cysteine (NAC) was used as a thiol containing 
protective agent since its hepatoprotective 
properties has been proven in many 
investigations (21-23). Cell death, reactive 
oxygen species (ROS) formation, lipid peroxi-
dation, protein carbonylation, and mitochondrial 
depolarization were assessed as toxicity 
markers after amodiaquine treatment and the 
protective effects of taurine and/or N-acetyl 
cysteine were evaluated.  
 
MATERIALS AND METHODS 
 
Animals 
Male Sprague–Dawley rats (weighing 250–
300 g) obtained from Tabriz University of 
Medical Sciences, Tabriz, Iran, was used. 
Animals were fed a standard chow diet and 
water ad libitum. The animals were handled 
and used, according to the animal handling 
protocol that approved by a local ethic 
committee in Tabriz University of Medical 
Sciences, Tabriz, Iran. 
 
Isolation and incubation of hepatocytes 
Hepatocytes were isolated from male 
Sprague–Dawley rats by collagenase perfusion 
method as described previously (24).               
The cells were suspended (1 × 106 cell/ml) in 
Krebs-Henseleit buffer containing 12.5 mM 
HEPES (4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid), and incubated under a 
stream of 95% O2 and 5% CO2. Glutathione- 
depleted hepatocytes were obtained by 
preincubating hepatocytes with 0.2 mM 
1-bromoheptane for 30 min (25). Taurine (200 
µM) was added 30 min before amodiaquine in 
all experiments. 
 
Cell viability 
Hepatocyte viability was assessed by 
plasma membrane disruption as determined by 
trypan blue uptake test (26). Cell viability was 
determined immediately after isolation and at 
scheduled time intervals following incubation. 
Approximately 85–90% of hepatocytes were 
viable at the time of isolation. 
 
Determination of reactive oxygen species  
Determinationn of ROS was carried out as 
explained previously (27). Briefly, 1.6 µM of 
DCFD-DA (2',7'-dichlorfluorescein-diacetate) 
was added to incubation media and at different 
time points, aliquots of 1 ml were withdrawn. 
These samples were centrifuged for 1 min             
at 3000 g. The fluorescence intensity of 
dichlorofluorescein was measured in supernatant 
using a Jasco® FP-750 fluorescence spectro-
photometer. Excitation and emission 
wavelengths were 490 nm and 520 nm, 
respectively (27). 
 
Determination of lipid peroxidation in 
hepatocytes 
Hepatocyte lipid peroxidation was 
determined by measuring the amount of 
thiobarbituric acid reactive substances (TBARS) 
formed during the decomposition of lipid 
hydroperoxides.  
One mL aliquot of hepatocyte suspension 
containing 106 cells/ml was treated with 
trichloroacetic acid (70% w/v) and the 
supernatant was boiled with thiobarbituric acid 
(0.8% w/v) for 20 min then, the absorbance of 
developed color was measured at 532 nm in a 
Ultrospec2000® spectrophotometer (28). 
 
Protein carbonylation assay 
Total protein-bound carbonyl content was 
measured by derivatizing the carbonyl adducts 
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with 2,4-dinitrophenyl hydrazine (DNPH). 
Briefly, an aliquot of the suspension of cells 
(0.5 mL, 0.5 × 106 cells) was added to an 
equivalent volume (0.5 mL) of 0.1% DNPH 
(w/v) in 2 N HCl and incubated for 1 h at 
room temperature in dark. This reaction was 
terminated and total cellular protein 
precipitated by the addition of an equivalent 
1.0 mL volume of 20% trichloroacetic acid 
(TCA) (w/v). Cellular protein was rapidly 
pelleted by centrifugation at 10,000 g, and the 
supernatant was discarded. Excess unin-
corporated dinitrophenylhydrazine (DNPH) was 
extracted three times using an excess volume 
(0.5 mL) of ethanol: ethyl acetate (1:1) 
solution.  
Following the extraction, the recovered 
cellular protein was solubilized in 1 mL of 
Tris-buffered 8.0 M guanidine–HCl, pH 7.2. 
The resulting solubilized hydrazones were 
measured at 380 nm by an Ultrospec2000 ® 
spectrophotometer (29). 
 
Mitochondrial membrane potential assay 
At different time points, 2 mL samples of 
the cell suspension were taken and centrifuged 
at 1000 g for 1 min. Then the cell pellet was 
resuspended in 2 ml of Krebs-Henseleit buffer 
containing 1.5 µM rhodamine 123 and 
incubated at 37 ºC water bath. Hepatocytes 
were separated by centrifugation at 3000 g for 
1 min and the amount of rhodamine 123 
appearing in the incubation medium was 
measured fluorimeterically using a Jasco® 
FP-750 fluorescence spectrophotometer  at 
490 nm excitation and 520 nm emission 
wavelengths. The capacity of mitochondria to 
take up the rhodamine 123 was calculated as 
the difference in fluorescence intensity 
between control and treated cells (30). 
 
RESULTS 
 
Amodiaquine-induced cytotoxicity 
Amodiaquine caused cytotoxicity toward 
isolated rat hepatocytes in a concentration 
dependent manner (Fig. 1). It was found that 1 
mM amodiaquine caused about 50% cell death 
in two hours (Lethal concentration 50%, 
LC50). Taurine and NAC were added to the 
incubation medium to determine their ability 
to modulate the toxic response. For this 
purpose, the LC50 of amodiaquine (1 mM) was 
selected. 
As shown in Fig. 2, Taurine (200 µM) and 
NAC (200 µM), effectively reduced 
amodiaquine-induced cell death. Treatment of 
hepatocytes with 1-bromoheptane (as a 
glutathione depletory agent) (25) beforehand, 
resulted in a dramatic increase in 
amodiaquine-induced cytotoxicity (Fig. 2). 
NAC effectively prevented cell death induced 
by amodiaquine in glutathione-depleted 
hepatocytes (Fig. 2) but taurine showed                
no significant effects in this situation             
(data not given).  
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Fig. 1. Concentration-response curves of amodiaquine-induced cytotoxicity toward isolated rat hepatocytes. Isolated rat 
hepatocytes (106 cells/mL) were incubated at 37°C in rotating round bottom flasks with 95% O2 and 5% CO2 in Krebs-
Henseleit buffer (pH 7.4). Data are given as Mean ± SEM for three independent experiments. *Different from control 
group (P<0.05). 
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Fig. 2. The effect of taurine , N-acetyl cysteine (NAC) and 1-bromoheptane (BHP) on amodiaquine-induced 
cytotoxicity toward isolated rat hepatocytes. Isolated rat hepatocytes (106 cells/mL) were incubated at 37°C in rotating 
round bottom flasks with 95% O2 and 5% CO2 in Krebs-Henseleit buffer (pH 7.4). Data are shown as Mean ± SEM for 
at least three separate experiments. aSignificantly different from control group (n=3, ANOVA, P<0.001). bSignificant 
difference as compared with amodiaquine-treated hepatocytes (n=3, ANOVA, P<0.05). cSignificantly different from 
amodiaquine-treated group (n=3, ANOVA, P<0.05). dSignificantly different from glutathione-depleted cells, which 
were treated with amodiaquine (n=3, ANOVA, P<0.001). 
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Fig. 3. Reactive oxygen species formation induced by amodiaquine and the protective effects of taurine and NAC. 
BHP: 1-bromoheptane. Isolated rat hepatocytes (106 cells/mL) were incubated at 37°C in rotating round bottom flasks 
with 95% O2 and 5% CO2 in Krebs-Henseleit buffer (pH 7.4). Data are expressed as Mean ± SEM for three independent 
experiments. aDifferent from control group (P<0.05). bSignificantly different from amodiaquine-treated hepatocytes 
(n=3, ANOVA, P<0.05). cSignificantly different from amodiaquine-treated cells (n=3, ANOVA, P<0.001). 
dSignificantly different from amodiaquine-treated cells which were depleted of glutathione (n=3, ANOVA, P<0.001). 
 
Amodiaquine-induced ROS formation 
A significant amount of ROS was formed 
when hepatocytes were treated with 
amodiaquine (Fig. 3), which could suggest the 
occurrence of oxidative stress after 
amodiaquine administration to hepatocytes. 
Pre-treatment of hepatocytes with taurine 
and/or addition of NAC to incubation medium 
reduced the level of ROS formation caused by 
amodiaquine (Fig. 3). Glutathione depletion 
resulted in a sharp increase in ROS formation 
induced by amodiaquine (Fig. 3). This might 
prove the vital role of glutathione against 
amodiaquine-induced oxidative stress and 
cytotoxicity. NAC effectively reduced the 
levels of ROS formed after amodiaquine in 
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glutathione-depleted hepatocytes (Fig. 3). 
Taurine was unable to reduce ROS levels in 
glutathione-depleted cells (data not given). 
 
Lipid peroxidation caused by amodiaquine 
Lipid peroxidation could be a consequence 
of ROS or reactive metabolites formation (31). 
When hepatocytes were incubated with 
amodiaquine, a significant amount of lipid 
peroxidation was detectable in normal cells 
(Fig. 4). The levels of lipid peroxidation were 
higher when glutathione-depleted cells were 
treated with amodiaquine (Fig. 4). Addition of 
taurine (200 µM) and/or NAC (200 µM) 
decreased the lipid peroxidation induced by 
amodiaquine in intact hepatocytes (Fig. 4). In 
glutathione-depleted cells, only NAC coun-
teracted the lipid peroxidation caused by 
amodiaquine (Fig. 4).  
 
Protein carbonylation 
Formation of carbonyl compounds is the 
most general and widely used marker of 
protein oxidation both in vitro and in vivo. It 
was found that protein carbonylation induced 
by amodiaquine was significantly higher than 
the control level (Fig. 5). Administration of 
taurine and/or NAC reduced the level of 
carbonylated proteins in amodiaquine-treated 
hepatocytes (Fig. 5). The level of carbonylated 
proteins raised when cellular glutathione 
reservoirs were depleted (Fig. 5). NAC 
effectively reduced protein carbonylation, 
induced by amodiaquine in glutathione-
depleted hepatocytes (Fig. 5). 
 
Amodiaquine-induced mitochondrial depolarization 
The possibility that subcellular components 
such as mitochondria are the target of 
amodiaquine to cause hepatocytes injury was 
investigated by evaluating the changes in 
mitochondrial membrane potential (∆Ψ) as a 
key parameter of mitochondrial function. The 
LC50 of amodiaquine (1 mM) caused reduction 
in mitochondrial membrane potential as 
measured with rhodamine 123 test (Fig. 6). 
This shows that mitochondria could be a target 
for amodiaquine or its reactive metabolite(s) to 
cause hepatocyte damage and consequently 
cell death. 
It was found that taurine and/or                  
NAC effectively prevented mitochondrial 
depolarization caused by amodiaquine (Fig. 6). 
Glutathione depletion deteriorated amodia-
quine-induced mitochondrial depolarization (Fig. 
6). Taurine could not reduce mitochondrial 
depolarization in glutathione-depleted hepato-
cytes (Fig. 6), but NAC effectively diminished 
mitochondrial depo-larization caused by 
amodiaquine in these cells (Fig. 6). 
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Fig. 4. TBARS formation induced by amodiaquine and the preventive role of taurine and/or N-acetyl cysteine. BHP: 
1-bromoheptane. Isolated rat hepatocytes (106 cells/mL) were incubated at 37°C in rotating round bottom flasks with 
95% O2 and 5% CO2 in Krebs-Henseleit buffer (pH 7.4). Data are shown as Mean ± SEM for three independent 
experiments as measured after 120 min of incubation. aDifferent from control group (n=3, ANOVA, P<0.05). bDifferent 
from amodiaquine-treated group (n=3, ANOVA, P<0.05). cDifferent from amodiaquine-treated group (n=3, ANOVA, 
P<0.05). dDifferent from amodiaquine-treated groups which were depleted of glutathione (BHP-treated) (n=3, ANOVA, 
P<0.05). 
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Fig. 5. Amodiaquine-induced protein carbonylation. The protective effects of taurine and/or N-acetyl cysteine. BHP: 
1-bromoheptane. Data are given as Mean ± SEM for at least three separate experiments as assessed 30 min after 
incubation. aSignificantly different from control group (n=3, ANOVA, P<0.05). bLower than amodiaquine-treated 
group (n=3, ANOVA, P<0.05). cHigher than amodiaquine-treated cells (n=3, ANOVA, P<0.05). dLower than 
amodiaquine-treated cells which were glutathione-depleted (n=3, ANOVA, P<0.05). 
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Fig. 6. Mitochondrial depolarization induced by amodiaquine and the role of NAC and/or taurine. Data are given as 
Mean ± SEM for at least three separate experiments as assessed 60 min after incubation. Isolated rat hepatocytes (106 
cells/mL) were incubated at 37°C in rotating round bottom flasks with 95% O2 and 5% CO2 in Krebs-Henseleit buffer 
(pH 7.4). a,bDifferent from control groups (n=3, ANOVA, P<0.05). cDifferent from amodiaquine-treated hepatocytes 
(n=3, ANOVA, P<0.05). dDifferent from amodiaquine-treated cells which were glutathione-depleted (n=3, ANOVA, 
P<0.05). 
 
DISCUSSION 
 
Different concentrations of amodiaquine 
caused cytotoxicity toward isolated rat 
hepatocytes. The toxicity was accompanied with 
ROS formation, lipid peroxidation, protein 
carbonylation, and mitochondrial depolarization. 
Taurine (200 µM) and/or NAC (200 µM) 
effectively attenuated the toxic effects of 
amodiaquine in hepatocytes, but only NAC had 
significant effects on amodiaquine-induced 
toxicity in glutathione-depleted cells. As 
revealed in previous investigations, amodia-
quine causes oxidative stress (32,33). We 
found that ROS level was elevated in 
amodiaquine-treated hepatocytes. This might 
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indicate the occurrence of oxidative stress in 
isolated hepatocytes after amodiaquine 
administration. Being an antioxidant, taurine 
and NAC can scavenge reactive species and 
attenuate oxidative stress (16,34). Hence, ROS 
formed during amodiaquine metabolism are 
scavenged by taurine and NAC which might 
have a role in their protective effects against 
amodiaquine cytotoxicity. 
Lipid peroxidation usually is one of the 
consequences of ROS formation and oxidative 
stress in biological systems (7). Taurine might 
reduce lipid peroxidation due to its ability in 
attenuating oxidative stress (35). Furthermore, 
taurine could chelate metal ions such as Fe2+ 
which could have a role in its ability in 
reducing lipid peroxidation (36). NAC is a 
well= recognized radical scavenger (34), and it 
is speculated that alleviation of oxidative stress 
and scavenging reactive species formed during 
amodiaquine metabolism could be involved in 
the protective effects of NAC against 
amodiaquine-induced hepatotoxicity. 
Protein carbonylation induced by reactive 
carbonyl species generated by peroxidation of 
polyunsaturated fatty acids play a significant 
role in the etiology of xenobiotics-induced 
cellular damage (37). Reducing oxidative 
stress and quenching reactive species (15), 
might be attributed to the protective effects of 
taurine against cellular protein damage caused 
by amodiaquine. 
Mitochondrial depolarization can cause 
energy crisis and releasing of apoptotic 
signaling molecules, which could finally 
encounter cell death (38). Decrease in 
mitochondrial membrane potential could be a 
consequence of ROS formation and oxidative 
stress (39), induced by amodiaquine. The 
protective effects of taurine and/or NAC against 
mitochondrial injury might be attributed to their 
effects against oxidative stress.  
Taurine administration ameliorated 
amodiaquine-induced toxicity in intact 
hepatocytes, but had no significant effect in 
glutathione-depleted cells. It has been shown 
that taurine affects some antioxidant enzymes 
(40). Since, in this study, the duration of 
treatment with taurine was not sufficient to 
upregulate antioxidant enzymes, taurine had 
no significant effect in glutathione-depleted 
cells. In intact hepatocytes, taurine by 
regulating cellular ions such as Ca2+, 
stabilizing cellular membrane and scavenging 
reactive species (11), restricts the oxidative 
stress induced by amodiaquine. However, in 
glutathione-depleted cells, where hepatocytes 
are in a more susceptible state and 
amodiaquine causes dramatic cytotoxicity, 
taurine is unable to protect cells. However, 
NAC as a more potent radical scavenger than 
taurine (41), prevented oxidative stress and 
toxicity induced by amodiaquine in both intact 
and glutathione-depleted rat hepatocytes. But 
taurine could not act effectively in this 
situation where a vast amount of ROS is 
formed by amodiaquine (Fig. 3), probably due 
to its weaker antioxidative and radical 
scavenging properties than NAC (15). 
 
CONCLUSION 
 
Our results indicate that taurine and/or 
NAC protect against the multiple targets            
of amodiaquine-induced damage toward 
hepatocytes. This study provides insight into 
the search for other implications of taurine 
against different drug-induced hepato-           
cytes injuries specially those, which are 
accompanied with oxidative stress. 
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